|
[1]European Association for the Study of the Liver.EASL clinical practice guidelines:management of cholestatic liver diseases[J].JHepatol,2009,51(2):237-267.
|
|
[2]DANAN G,BENICHOU C.Causality assessment of adverse reactions to drugs-I.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries[J].J Clin Epidemiol,1993,46(11):1323-1330.
|
|
[3]ZENG LL,ZHOU GQ.Diagnostic criteria of drug-induced liver injury and their clinical application[J].ADRJ,2011,13(1):17-20.(in Chinese)曾玲玲,周桂琴.药物性肝损害诊断标准及其临床应用[J].药物不良反应杂志,2011,13(1):17-20.
|
|
[4]ZHOU XY,TIAN YZ.The recent advances in the treatment of refractory primary biliary cirrhosis[J].Jilin J Tradit Chin Med,2014,34(11):1185-1188.(in Chinese)周新源,田耀洲.难治性原发性胆汁性肝硬化治疗进展[J].吉林中医药,2014,34(11):1185-1188.
|
|
[5]CHEN QB,PENG AP,LI CC,et al.Suppressive effects of bezafibrate on proliferation and cytokine production by CD4+T cells from patients with primary biliary cirrhosis[J].Chin J Immunol,2014,30(10):1388-1392.(in Chinese)陈曲波,彭桉平,黎翠翠,等.苯扎贝特对原发性胆汁性肝硬化患者外周血CD4+T细胞的抑制作用研究[J].中国免疫学杂志,2014,30(10):1388-1392.
|
|
[6]HU Q,LIU W,SHAO H.Research progress of pharmacotherapy drug-induced liver injury[J].Chin J Clin Pharmacol Ther,2016,21(2):231-236.(in Chinese)胡琴,刘维,邵宏.药物性肝损伤的药物治疗研究进展[J].中国临床药理学与治疗学,2016,21(2):231-236.
|
|
[7]BNICHOU C.Criteria of drug-induced liver disorders.Report of an international consensus meeting[J].J Hepatol,1990,11(2):272-276.
|
|
[8]NAVARRO V.Hepatic adverse event nomenclature document[EB/OL].(2006-11-17)[2015-09-21].http://www.fda.gov/cder/livertox/presentaions 2005/vic_Navarro.ppt.
|
|
[9]WATKINS P,SEEFF LB.Drug-induced liver injury:summary of a single topic clinical research conference[J].Hepatology,2006,43(3):618-631.
|
|
[10]SHAKIL A,KRAMER D,MAZARIEGOS G,et al.Acute liver failure:clinical features,outcome analysis,and applicability of prognostic criteria[J].Liver Transpl,2000,6(2):163-169.
|
|
[11]LINDOR KD,GERSHWIN ME,POUPON R,et al.Primary biliary cirrhosis[J].Hepatology,2009,50(1):291-308.
|
|
[12]FONTANA RJ,SEEFF LB,ANDRADE RJ,et al.Standardization of nomenclature and causality assessment in drug-induced liver injury:summary of a clinical research workshop[J].Hepatology,2010,52(2):730-742.
|
|
[13]CHALASANI N,FONTANA RJ,BONKOVSKY HL,et al.Causes,clinical features,and outcomes from a prospective study of drug induced liver injury in the United States[J].Gastroenterology,2008,135(6):1924-1934.
|
|
[14]WANG J,LIU DW,ZHAN SY.The advancement in epidemiological study of drug-induced liver disease[J].Mod Prev Med,2010,37(7):1393-1395.(in Chinese)王剑,刘殿武,詹思延.药物性肝病流行病学研究进展[J].现代预防医学,2010,37(7):1393-1395.
|
|
[15]HIRSCHFIELD GM.Diagnosis of primary biliary cirrhosis[J].Best Pract Res Clin Gastroenterol,2011,25(6):701-712.
|
|
[16]ANDRADE RJ,LUCENA MI,KAPLOWITZ N,et al.Outcome of acute idiosyncratic drug-induced liver injury:long-term follow-up in a hepatotoxity registry[J].Hepatology,2006,44(6):1581-1588.
|
|
[17]WATKINS PB,SEEFF LB.Drug-induced liver injury:summary of a single topic clinical research conference[J].Hepatology,2006,43(3):618-631.
|
|
[18]TENG GJ,ZHANG W,SUN Y,et al.Three cases of drug-induced hepatitis developing into autoimmune liver disease:a literature review[J].Chin Hepatol,2010,15(5):397-399.(in Chinese)滕光菊,张伟,孙颖,等.药物性肝炎发展为自身免疫性肝病3例文献复习[J].肝脏,2010,15(5):397-399.
|
|
[19]SOHDA T,SHIGA H,NAKANE H,et al.Rapid-onset primary biliary cirrhosis resembling drug-induced liver injury[J].Intern Med,2005,44(10):1051-1054.
|
|
[20]WANG XX,LIU YM,LIU H,et al.Clinical pathology features analysis of drug-induced liver injury in patients with autoantibodies[J].China Med Herald,2013,10(25):85-87.(in Chinese)王欣欣,刘燕敏,刘晖,等.自身抗体阳性的药物性肝损害临床病理特点分析[J].中国医药导报,2013,10(25):85-87.
|
|
[21]RAO YF,ZHENG FY,ZHANG XG.Immunological mechanisms of drug-induced liver injury(DILI)[J].Chin Pharmacol J,2008,43(16):1207-1210.(in Chinese)饶跃峰,郑飞跃,张幸国.药物性肝损伤的免疫学机制[J].中国药学杂志,2008,43(16):1207-1210.
|
|
[22]LIU YM.The clinical feature and prognosis in patients with drug induced liver injury complicated with positive autoantibodies detection[J].J Clin Hepatol,2012,28(5):335-338.(in Chinese)刘燕敏.药物性肝损害伴自身抗体阳性患者临床特征及转归[J].临床肝胆病杂志,2012,28(5):335-338.
|
|
[23]FAN LY,ZHONG RQ.Studies on pathogenesis of primary biliary cirrhosis[J].Chin J Hepatol,2002,10(5):392-394.(in Chinese)范列英,仲人前.原发性胆汁性肝硬化发病机制研究进展[J].中华肝脏病杂志,2002,10(5):392-394.
|
|
[24]DEGOTT C,FELDMANN G,LARREY D,et al.Drug-induced prolonged cholestasis in adults:a histological semiquantitative study demonstrating progressive ductopenia[J].Hepatology,1992,15(2):244-251.
|
DownLoad: